Literature DB >> 27923224

Why Should Phase 1 Cancer Trial Participation and Optimal End-of-Life Care Be Incompatible?

Maurie Markman1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27923224     DOI： 10.1159/000452161

Source DB:  PubMed          Journal:  Oncology        ISSN： 0030-2414            Impact factor:   2.935


× No keyword cloud information.
  1 in total

1.  Reasons for acceptance and refusal of early palliative care in patients included in early-phase clinical trials in a regional comprehensive cancer centre in France: protocol for a qualitative study.

Authors:  Gisele Chvetzoff; Magali Girodet; Johanna Despax; Valentine Baudry; Julie Duranti; Bénédicte Mastroianni; Hélène Vanacker; Armelle Vinceneux; Mehdi Brahmi; Olivier Renard; Julien Gautier; Manon Britel; Françoise Ducimetière; Amélie Anota; Philippe Cassier; Véronique Christophe
Journal:  BMJ Open       Date:  2022-04-22       Impact factor: 3.006
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.